Assessments | Baseline | Week 13 | Week 26 | Week 49 |
---|---|---|---|---|
Sociodemographic characteristics | X | Â | Â | X |
Drug use history | X | Â | X | X |
Current drug use | X | Â | X | X |
 Amphetamine use behaviors |  |  |  |  |
 Amphetamine Cessation Symptom Assessment (ACSA) |  |  |  |  |
Tobacco smoking | X | Â | X | X |
Alcohol use (AUDIT-C) | X | Â | X | X |
Barriers to access to care | X | Â | X | X |
 BACE |  |  |  |  |
Mental health | X | Â | X | X |
 Depression, Anxiety, Stress Scale (DASS-21) |  |  |  |  |
Social support (MOS-SS) | X | Â | X | X |
Quality of life (EQ-5D-5L) | X | Â | Â | X |
Stigmatization | X | Â | Â | X |
 Towards people who are under methadone treatment (MMT-SMS) |  |  |  |  |
 Toward people who use drugs |  |  |  |  |
 Toward people living with HIV |  |  |  |  |
Treatment information (from medical charts) | X | X | X | X |
 Methadone maintenance treatment |  |  |  |  |
 HIV treatment |  |  |  |  |
Cost data | X | Â | X | X |
 Opportunity costs |  |  |  |  |
 Other healthcare costs |  |  |  |  |
 Social costs |  |  |  |  |
Tests | ||||
 Quick and confirmatory HIV tests (not for participants with known HIV seropositivity) | X | X | X | X |
 Viral load test | X | X | X | X |
 UDS | Twice a week throughout intervention | X | ||
Ethnographic observation | X | X | X | X |
Qualitative interviews | X | Â | X | Â |